AVITA Medical (RCEL) News Today → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free RCEL Stock Alerts $8.19 -0.08 (-0.97%) (As of 02:33 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 4:02 AM | americanbankingnews.comCantor Fitzgerald Comments on AVITA Medical, Inc.'s FY2024 Earnings (NASDAQ:RCEL)May 16, 2024 | globenewswire.comAVITA Medical to Host Investor Webinar BriefingMay 16, 2024 | marketbeat.comCantor Fitzgerald Analysts Raise Earnings Estimates for AVITA Medical, Inc. (NASDAQ:RCEL)AVITA Medical, Inc. (NASDAQ:RCEL - Free Report) - Analysts at Cantor Fitzgerald upped their FY2024 earnings per share estimates for shares of AVITA Medical in a research note issued to investors on Tuesday, May 14th. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will post eMay 16, 2024 | americanbankingnews.comAVITA Medical (NASDAQ:RCEL) Stock Rating Reaffirmed by Piper SandlerMay 16, 2024 | americanbankingnews.comAVITA Medical (NASDAQ:RCEL) PT Lowered to $21.00 at Cantor FitzgeraldMay 15, 2024 | marketbeat.comAVITA Medical (NASDAQ:RCEL) Announces Earnings Results, Misses Expectations By $0.47 EPSAVITA Medical (NASDAQ:RCEL - Get Free Report) posted its earnings results on Monday. The company reported ($0.73) EPS for the quarter, missing the consensus estimate of ($0.26) by ($0.47). AVITA Medical had a negative return on equity of 54.80% and a negative net margin of 70.56%. During the same period last year, the business earned ($0.37) EPS.May 15, 2024 | msn.comPiper Sandler Downgrades AVITA Medical (RCEL)May 14, 2024 | markets.businessinsider.comPiper Sandler Reaffirms Their Hold Rating on Avita Medical (RCEL)May 14, 2024 | markets.businessinsider.comAnalyst Ratings For AVITA MedicalMay 14, 2024 | marketbeat.comAVITA Medical (NASDAQ:RCEL) Rating Reiterated by Piper SandlerPiper Sandler reaffirmed a "neutral" rating and set a $9.00 price objective (down previously from $21.00) on shares of AVITA Medical in a research report on Tuesday.May 14, 2024 | marketbeat.comCantor Fitzgerald Lowers AVITA Medical (NASDAQ:RCEL) Price Target to $21.00Cantor Fitzgerald reduced their price objective on shares of AVITA Medical from $22.00 to $21.00 and set an "overweight" rating on the stock in a research note on Tuesday.May 14, 2024 | msn.comAVITA Medical, Inc. (NASDAQ:RCEL) Q1 2024 Earnings Call TranscriptMay 14, 2024 | finance.yahoo.comAVITA Medical Inc (AVHHL) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges ...May 13, 2024 | globenewswire.comAVITA Medical Reports First Quarter Financial ResultsMay 12, 2024 | msn.comAVITA Medical Q1 2024 Earnings PreviewApril 27, 2024 | marketbeat.comAVITA Medical, Inc. (NASDAQ:RCEL) Short Interest UpdateAVITA Medical, Inc. (NASDAQ:RCEL - Get Free Report) was the recipient of a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 1,180,000 shares, an increase of 62.5% from the March 31st total of 726,200 shares. Approximately 5.0% of the company's shares are sold short. Based on an average daily volume of 228,300 shares, the days-to-cover ratio is currently 5.2 days.April 19, 2024 | morningstar.comAVITA Medical Inc RCELApril 15, 2024 | globenewswire.comAVITA Medical to Announce First Quarter 2024 Financial ResultsApril 15, 2024 | marketbeat.comShort Interest in AVITA Medical, Inc. (NASDAQ:RCEL) Grows By 22.9%AVITA Medical, Inc. (NASDAQ:RCEL - Get Free Report) was the target of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 726,200 shares, a growth of 22.9% from the March 15th total of 590,700 shares. Based on an average daily volume of 165,600 shares, the days-to-cover ratio is currently 4.4 days. Approximately 3.1% of the shares of the company are sold short.April 11, 2024 | investing.comAvita Medical Ltd (RCEL)April 11, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Fate Therapeutics (FATE), Disc Medicine (IRON) and Avita Medical (RCEL)April 11, 2024 | seekingalpha.comBTIG downgrades Avita to neutral, cites lowered guidanceApril 11, 2024 | marketbeat.comAVITA Medical (NASDAQ:RCEL) Rating Lowered to Neutral at BTIG ResearchBTIG Research cut shares of AVITA Medical from a "buy" rating to a "neutral" rating in a research note on Thursday.April 10, 2024 | globenewswire.comAVITA Medical Updates Expected First Quarter 2024 RevenueMarch 16, 2024 | finance.yahoo.comRCEL Apr 2024 22.500 putMarch 16, 2024 | finance.yahoo.comRCEL Oct 2024 17.500 putMarch 5, 2024 | seekingalpha.comAVITA Medical: Unconvincing Growth Amid Fierce Competition In The Burn Care SectorFebruary 29, 2024 | finance.yahoo.comAVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA SupplementFebruary 29, 2024 | globenewswire.comAVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA SupplementFebruary 29, 2024 | globenewswire.comAVITA Medical to Present at TD Cowen 44th Annual Health Care ConferenceFebruary 29, 2024 | marketbeat.comFY2024 EPS Estimates for AVITA Medical, Inc. (NASDAQ:RCEL) Cut by Cantor FitzgeraldAVITA Medical, Inc. (NASDAQ:RCEL - Free Report) - Analysts at Cantor Fitzgerald decreased their FY2024 earnings per share estimates for shares of AVITA Medical in a research report issued on Monday, February 26th. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will post earnFebruary 26, 2024 | nasdaq.comAVITA Medical (RCEL) Price Target Increased by 6.80% to 26.69February 26, 2024 | sg.finance.yahoo.comBRIEF-Seatrium Limited Says FY Revenue S$7.3 BlnFebruary 23, 2024 | markets.businessinsider.comAvita Medical Poised for Growth: Strong Q4 Performance and Promising 2024 Outlook Reinforce Buy RatingFebruary 23, 2024 | marketbeat.comAVITA Medical (NASDAQ:RCEL) Receives "Overweight" Rating from Piper SandlerPiper Sandler reissued an "overweight" rating and issued a $21.00 price objective (up from $19.00) on shares of AVITA Medical in a report on Friday.February 23, 2024 | finance.yahoo.comAVITA Medical, Inc. (NASDAQ:RCEL) Q4 2023 Earnings Call TranscriptFebruary 23, 2024 | marketbeat.comCantor Fitzgerald Boosts AVITA Medical (NASDAQ:RCEL) Price Target to $25.00Cantor Fitzgerald upped their price objective on shares of AVITA Medical from $22.00 to $25.00 and gave the stock an "overweight" rating in a research report on Friday.February 23, 2024 | globenewswire.comAVITA Medical to Host Investor Webinar BriefingFebruary 23, 2024 | msn.comArdelyx Posts Q4 Loss, Joins MercadoLibre, Booking Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market SessionFebruary 23, 2024 | markets.businessinsider.comBuy Rating Affirmed for Avita Medical on Strong Financials and Expansive Growth StrategyFebruary 22, 2024 | globenewswire.comAVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial GuidanceFebruary 21, 2024 | msn.comAVITA Medical Q4 2023 Earnings PreviewFebruary 17, 2024 | finance.yahoo.comRCEL Mar 2024 15.000 callFebruary 15, 2024 | marketbeat.comAVITA Medical (RCEL) Scheduled to Post Earnings on ThursdayAVITA Medical (NASDAQ:RCEL) will be releasing earnings after the market closes on Thursday, February 22, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=564348)February 7, 2024 | finance.yahoo.comAVITA Medical, Inc. (NASDAQ:RCEL): Are Analysts Optimistic?February 1, 2024 | finance.yahoo.comAVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial ResultsJanuary 19, 2024 | marketbeat.comCantor Fitzgerald Increases AVITA Medical (NASDAQ:RCEL) Price Target to $22.00Cantor Fitzgerald lifted their price objective on AVITA Medical from $20.00 to $22.00 and gave the company an "overweight" rating in a research note on Friday.January 14, 2024 | marketbeat.comShort Interest in AVITA Medical, Inc. (NASDAQ:RCEL) Increases By 14.9%AVITA Medical, Inc. (NASDAQ:RCEL - Get Free Report) was the recipient of a large growth in short interest during the month of December. As of December 31st, there was short interest totalling 585,900 shares, a growth of 14.9% from the December 15th total of 510,000 shares. Approximately 2.4% of the shares of the company are sold short. Based on an average daily trading volume, of 164,700 shares, the days-to-cover ratio is presently 3.6 days.January 12, 2024 | markets.businessinsider.comAvita Medical Poised for Growth: Buy Rating and $40 Price Target Justified by Strategic Partnerships and Positive Financial IndicatorsJanuary 10, 2024 | finance.yahoo.comAVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific Get AVITA Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. RCEL Media Mentions By Week RCEL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCEL News Sentiment▼0.030.42▲Average Medical News Sentiment RCEL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCEL Articles This Week▼212▲RCEL Articles Average Week Get AVITA Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AngioDynamics News Utah Medical Products News TriSalus Life Sciences News Inovio Pharmaceuticals News Sight Sciences News Profound Medical News Fractyl Health News Orchestra BioMed News CVRx News Accuray News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RCEL) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaProtect Your Bank Account Before It’s Too LateWeiss RatingsThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestThis military-backed stock “owns” AI marketPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
